Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders

Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders

US Patent 11160850 · Granted Nov 2, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stabilized liquid and lyophilized ADAMTS13 formulations2024
TFPI inhibitors and methods of use2023
TFPI inhibitors and methods of use2023
Viral vectors encoding recombinant FVIII variants with increased expression for 2023
Gene therapy of hemophilia B using viral vectors encoding recombinant fix varian2023
Stabilized liquid and lyophilized ADAMTS13 formulations2023
Nucleophilic catalysts for oxime linkage2023
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Anti-MIF immunohistochemistry2022
Viral vectors encoding recombinant FVIII variants with increased expression for 2022
Lyophilized recombinant VWF formulations2021
Lyophilized recombinant VWF formulations2021